Glaxo Working to Accelerate Ebola Treatment

Oct. 20 (Bloomberg) -- Bloomberg’s Sam Fazeli reports on drug companies racing for an Ebola vaccine and treatment drugs. He speaks with Jonathan Ferro on Bloomberg Television’s “On The Move.” (Source: Bloomberg)

Marathon CEO on Distressed Debt and Drug Pricing
21:45 - Marathon Asset Management CEO Bruce Richards discusses investment opportunities in distressed E&P debt and price gouging in the pharmaceutical industry. He speaks with Bloomberg's Vonnie Quinn on "Bloomberg Markets.” (Source: Bloomberg)
  • Marathon CEO Says Health Care Is ‘Most Corrupt Industry’
  • Trump Calls Drug Pricing ‘Astronomical’
  • Trump: Get Drug Prices Down, Streamline FDA Approvals